1. Hilal-Dandan R, Brunton LL. Goodman and Gilman’s Manual of Pharmacology and Therapeutics. 2nd ed. China: McGraw Hill Professional; 2014. pp. 523-543
2. Adams RL, Bird RJ. Review article: Coagulation cascade and therapeutics update: Relevance to nephrology. Part 1: Overview of coagulation, thrombophilias and history of anticoagulants. Nephrology (Carlton, Vic.). 2009;14(5):462-470. DOI: 10.1111/j.1440-1797.2009.01128.x
3. Garcia DA, Baglin TP, Weitz JI, Samama MM. Parenteral anticoagulants: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e24S-e43S. DOI: 10.1378/chest.11-2291
4. Smythe MA, Priziola J, Dobesh PP, Wirth D, Cuker A, Wittkowsky AK. Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolism. Journal of Thrombosis and Thrombolysis. 2016;41(1):165-186. DOI: 10.1007/s11239-015-1315-2
5. Maddali S, Biring T, Bluhm J, Kopecky S, Krueger K, Larson T, et al. Institute for Clinical Systems Improvement. Antithrombotic Therapy Supplement. Updated February 2013